When evaluating the option to buy bronchogen nitrogenous bases price structures across suppliers, researchers must balance analytical verification against lot-to-lot consistency. High-purity synthetic Bronchogen tetrapeptide reagent is priced based on sequence fidelity, HPLC purity metrics, and verified endotoxin thresholds. PX1 Research supplies reference-standard Bronchogen strictly for in vitro and laboratory research applications.
When evaluating the option to buy bronchogen nitrogenous bases price structures across suppliers, researchers must balance analytical verification against lot-to-lot consistency. High-purity synthetic Bronchogen tetrapeptide reagent is priced based on sequence fidelity, HPLC purity metrics, and verified endotoxin thresholds. PX1 Research supplies reference-standard Bronchogen strictly for in vitro and laboratory research applications.
In biomedical research, determining the true cost of short-chain peptide bioregulators involves analyzing mass purity, peptide content verification, and stringent quality control standards. When investigating options to buy bronchogen nitrogenous bases price ranges typically reflect the rigor of the underlying synthesis and purification workflows. Substandard formulations may offer lower entry costs but frequently introduce uncharacterized synthesis fragments, high counter-ion variations, or elevated bacterial endotoxin levels that skew in vitro cell culture models.
PX1 Research maintains transparent pricing structures for high-grade Bronchogen research reagents, ensuring every lot undergoes comprehensive testing before release. Laboratory buyers evaluating unit pricing must account for analytical verification guarantees, including high-performance liquid chromatography (HPLC) mass purity and electrospray ionization mass spectrometry (ESI-MS) identity validation. Accessing standardized, high-purity reagents prevents costly experimental artifacts and ensures reproducible data across cellular assays.
Bronchogen is a synthetic short-chain bioregulatory peptide composed of four amino acid residues: L-alanyl-L-alpha-aspartyl-L-alpha-glutamyl-L-leucine (Ala-Asp-Glu-Leu). With a molecular formula of C18H30N4O9 and a baseline molecular weight of approximately 446.45 g/mol, it belongs to the class of Khavinson peptide bioregulators engineered to mimic natural chromatin-modulating short peptides.
The molecular design of Bronchogen focuses on specific peptide-nucleic acid electrostatic interactions. In biochemical assays, the acidic residues (Asp and Glu) provide localized negative charges, while the overall peptide conformation permits site-specific binding within the major and minor grooves of double-stranded DNA. Researchers studying chromatin remodeling frequently evaluate how synthetic short chains modulate histone acetylation and gene expression profiles in bronchial epithelial cell lines.
A central focus of short peptide research is the physical interaction between oligopeptide sequences and the nitrogenous bases (adenine, thymine, cytosine, and guanine) of nuclear chromatin. Preclinical molecular docking and spectroscopy studies demonstrate that short peptides like Bronchogen can hydrogen-bond to specific nitrogenous base sequences within promoter regions.
This site-specific binding alters the localized spatial organization of DNA, potentially facilitating or restricting transcription factor access. In vitro assays using purified genomic DNA suggest that short peptide sequences exhibit sequence preference, interacting distinctively with GC-rich or AT-rich sequences. Studying these nitrogenous base interactions aids researchers in mapping epigenomic regulatory mechanisms without gene editing vectors.
In vitro and animal model studies have evaluated Bronchogen for its potential influence on respiratory tissue homeostasis and cellular aging pathways. Preclinical rodent models investigating pulmonary tissue stress indicate that Bronchogen administration may modulate inflammatory signal cascades, including NF-kB and specific interleukin profiles, within pulmonary parenchyma.
Furthermore, cell culture assays involving human bronchial epithelial cells demonstrate that exposure to synthetic Bronchogen supports cell viability and structural integrity under hypoxic or oxidative stress conditions. These findings position Bronchogen as a primary subject in studies examining epithelial barrier preservation, mucociliary clearance mechanisms, and extracellular matrix remodeling. Researchers can explore broader bioregulatory frameworks via our research peptide library hub.
Bronchogen operates within a broader family of short-chain synthetic bioregulators designed for target-tissue epigenetic research. Evaluating structural and functional differences among these short sequences helps research teams select the precise peptide target for their specific tissue model.
While Bronchogen specifically targets pulmonary and epithelial cell pathways, related short peptides show affinity for different organ systems. For instance, Vilon (Lys-Glu) is extensively investigated for immune cell regulation and splenocyte reactivation. Similarly, Epitalon (Ala-Glu-Asp-Gly) is studied for pineal gland function and telomerase activity modulation, whereas Cartalax (Ala-Glu-Asp) targets chondrocyte differentiation and cartilage extracellular matrix synthesis. Comparing these distinct amino acid sequences helps clarify how minor structural changes redirect peptide-nitrogenous base binding specificity.
When purchasing research compounds, reliable pricing must be backed by transparent quality verification. PX1 Research tests every batch of Bronchogen using reverse-phase HPLC (RP-HPLC) to guarantee a purity threshold of ≥98.0%. Mass spectrometry assays confirm accurate molecular weight identity, ensuring the complete absence of truncated sequences or residual protecting groups from automated peptide synthesis.
Crucially for cell culture and preclinical research, bacterial endotoxins must be rigorously controlled. Chromogenic LAL (Limulus Amebocyte Lysate) testing ensures endotoxin levels remain below <0.5 EU/mg. Uncontrolled endotoxins alter immune signaling pathways in primary cells, invalidating experimental results. Every order includes a lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited analytical laboratory.
Proper handling and reconstitution protocols are vital to maintain the structural integrity of synthetic peptides in laboratory environments. Bronchogen is supplied as a sterile, lyophilized white powder under vacuum seal to maximize shelf-life stability during storage and transit.
For reconstitution, investigators should utilize sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) under a laminar flow hood. Gently reconstitute by running the solvent down the side of the glass vial rather than jetting liquid directly onto the lyophilized cake. Allow the cake to dissolve naturally without vigorous vortexing, which can introduce shear stress and induce peptide aggregation. To browse available reagents for your lab, view our complete catalog of all research peptides.
Lyophilized Bronchogen should be stored at -20°C upon receipt for long-term stability (up to 24 months). Protection from light and moisture desiccation prevents hydrolytic degradation of the peptide backbone.
Once reconstituted into aqueous solution, aliquots should be prepared to avoid repeated freeze-thaw cycles, which degrade peptide purity over time. Liquid aliquots are stable at 4°C for up to 7–14 days, or at -80°C for extended experimental protocols. Following standardized cold-chain handling protocols protects the fidelity of your quantitative assays.
Sourcing peptides manufactured in the USA within cGMP-compliant facilities minimizes supply chain disruption and guarantees strict adherence to quality assurance standards. PX1 Research operates centralized logistics hubs in California and Arizona to support fast, reliable delivery to domestic and international academic and corporate laboratories.
Orders placed before 12:00 PM PST Monday through Friday ship same-day via expedited courier services with ambient temperature monitoring. Reliable shipping parameters prevent thermal stress during transit, ensuring lyophilized products arrive in optimal physical and chemical condition.
Whether executing preliminary proof-of-concept assays or running high-throughput screening initiatives, research laboratories require flexible procurement options. Individual standard reference vials allow small-scale validation, while volume-based ordering provides cost efficiency for multi-phase projects.
For institutional procurement, university departments, and corporate research organizations requiring bulk quantities, PX1 Research offers dedicated bulk pricing structures and customized lot reservation. Qualified principal investigators can apply for a wholesale research account to access volume pricing, dedicated account management, and standardized multi-lot batch holds.
What is Bronchogen used for in laboratory research?
Bronchogen is a research-grade synthetic tetrapeptide (Ala-Asp-Glu-Leu) studied in vitro and in animal models to evaluate its effects on respiratory epithelial tissue, epigenomic chromatin remodeling, and cellular inflammatory cascades.
How does Bronchogen interact with nitrogenous bases?
Preclinical studies suggest that short bioregulatory peptides like Bronchogen hydrogen-bond to specific double-stranded DNA sequences and nitrogenous bases within gene promoter regions, potentially influencing histone modification and transcription factor binding.
What factors influence the buy bronchogen nitrogenous bases price?
Pricing is determined by peptide sequence purity (typically ≥98% via RP-HPLC), mass spectrometry validation, low endotoxin limits (<0.5 EU/mg), lot traceability, and ISO 17025 third-party COA verification.
Is Bronchogen approved for human clinical use or consumption?
No. Bronchogen is sold strictly for in vitro and laboratory research applications. It is not approved for human or veterinary medical use, therapeutic administration, diagnosis, or consumption.
What solvent is recommended for Bronchogen reconstitution?
In laboratory settings, Bronchogen is typically reconstituted using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) under sterile laminar flow conditions.
What is the recommended storage temperature for lyophilized Bronchogen?
Lyophilized Bronchogen vials should be stored at -20°C in a dry, dark environment upon receipt. Reconstituted aliquots should be frozen at -80°C to prevent freeze-thaw degradation.
How does PX1 Research verify Bronchogen batch quality?
PX1 Research verifies every lot using RP-HPLC for purity, ESI-MS for molecular mass confirmation, and chromogenic LAL assays for endotoxins. A lot-specific Certificate of Analysis is accessible with every purchase.
What peptides are structurally comparable to Bronchogen?
Bronchogen belongs to the short bioregulator class alongside peptides such as Vilon (Lys-Glu), Epitalon (Ala-Glu-Asp-Gly), and Cartalax (Ala-Glu-Asp), each targeting distinct tissue specificity and gene promoter interactions.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.